Derivatives of pharmaceutical compounds that could potentially bind irreversibly to a hypertension controlling receptor were synthesised to provide tools for studying this receptor. Also compounds that simultaneously activate two cardiovascular receptors with opposing cellular mechanisms were synthesised. This resulted in a desired partial reduction in the activity of one receptor
Notes
Submitted to the Centre for Chiral and Molecular Technologies, School of Biological and Chemical Sciences of the Faculty of Science and Technology, Deakin University